Ipswich Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
+9,035
| New | +$249K | 0.06% | 164 |
|
|
2024
Q4 | – | Sell |
-4,795
| Closed | -$320K | – | 196 |
|
|
2024
Q3 | $320K | Sell |
4,795
-1,235
| -20% | -$82.5K | 0.07% | 152 |
|
|
2024
Q2 | $716K | Sell |
6,030
-238
| -4% | -$28.3K | 0.17% | 103 |
|
|
2024
Q1 | $668K | Sell |
6,268
-695
| -10% | -$74.1K | 0.16% | 112 |
|
|
2023
Q4 | $692K | Sell |
6,963
-7,205
| -51% | -$717K | 0.18% | 106 |
|
|
2023
Q3 | $1.46M | Sell |
14,168
-645
| -4% | -$66.6K | 0.4% | 63 |
|
|
2023
Q2 | $1.8M | Sell |
14,813
-470
| -3% | -$57.1K | 0.47% | 58 |
|
|
2023
Q1 | $2.35M | Sell |
15,283
-162
| -1% | -$24.9K | 0.64% | 47 |
|
|
2022
Q4 | $2.77M | Sell |
15,445
-138
| -0.9% | -$24.8K | 0.79% | 42 |
|
|
2022
Q3 | $1.84M | Sell |
15,583
-835
| -5% | -$98.8K | 0.59% | 52 |
|
|
2022
Q2 | $2.35M | Sell |
16,418
-283
| -2% | -$40.4K | 0.67% | 45 |
|
|
2022
Q1 | $2.88M | Buy |
16,701
+1,207
| +8% | +$208K | 0.71% | 47 |
|
|
2021
Q4 | $3.94M | Buy |
15,494
+3,845
| +33% | +$977K | 0.92% | 36 |
|
|
2021
Q3 | $4.48M | Sell |
11,649
-617
| -5% | -$237K | 1.15% | 22 |
|
|
2021
Q2 | $2.88M | Buy |
12,266
+5,906
| +93% | +$1.39M | 0.74% | 48 |
|
|
2021
Q1 | $833K | Buy |
+6,360
| New | +$833K | 0.23% | 100 |
|